Investor · Philadelphia, PA

Martin Edwards

Open Martin in the network graph →

Filings

15

SEC Form D

Connections

70

co-filers

Capital

$81.0M

across filings

Active

Mar 2012

to Jun 2020

Most-connected co-filers (70)

Joseph Schlessinger · Boston, MA6 shared Morgan Creek Capital Management, LLC · Chapel Hill, NC5 shared Edward Mathers · Cambridge, MA5 shared Reinaldo Diaz · Boston, MA5 shared Axel Bolte · Boston, MA5 shared Rob Hopfner · Boston, MA5 shared Robert D. Ghiselli · Glendale, CO4 shared Sean Mullins · Indianapolis, IN4 shared Lewis Geffen · BOSTON, MA4 shared Matthew Goebel · Chicago, IL4 shared Daniel J. Hopkins · Evanston, IL4 shared Michael J. Hughes · Evanston, IL4 shared GGV Discovery II L.L.C · Menlo Park, CA4 shared Sean Lavies · Indianapolis, IN4 shared Robert Saunders · Chicago, IL4 shared Eric Bednarski · Waltham, MA4 shared Harley Miller · Brooklyn, NY4 shared Gregory Lumpkin · Philadelphia, PA4 shared Eric Huebner · Carmel, IN4 shared James B. Tananbaum · SAN FRANCISCO, CA4 shared William Bennett · Chicago, IL4 shared David Brand · Philadelphia, PA4 shared Andrew Denardo · Red Bank, NJ4 shared Sarah Bhagat · Boston, MA3 shared

Recent filings (15)

Inozyme Pharma, Inc.Jun 2020 · 15 co-filers$67.4M Inozyme Pharma, Inc.Jun 2020 · 15 co-filers$67.4M Inozyme Pharma, Inc.Mar 2020 · 20 co-filers$33.7M Inozyme Pharma, Inc.Mar 2019 · 20 co-filers$33.7M Elysium Therapeutics, Inc.Mar 2019 · 11 co-filers$1.5M Inozyme Pharma, Inc.Nov 2018 · 17 co-filers$48.9M Inozyme Pharma, Inc.Nov 2018 · 17 co-filers$10.7M Elysium Therapeutics, Inc.Sep 2018 · 7 co-filers$2.3M Stargazer Pharmaceuticals, Inc.Apr 2018 · 8 co-filers$8.7M Stargazer Pharmaceuticals, Inc.Apr 2018 · 8 co-filers$8.7M Polymbios Capital Global Fund, Ltd.Jan 2018 · 10 co-filers Polymbios Capital LPDec 2017 · 10 co-filers Elysium Therapeutics, Inc.Dec 2017 · 11 co-filers$1.5M Tarsa Therapeutics, Inc.Jan 2017 · 15 co-filers$1.6M Tarsa Therapeutics, Inc.Jan 2017 · 15 co-filers$1.6M Tarsa Therapeutics, Inc.Jul 2016 · 20 co-filers$1.3M Tarsa Therapeutics, Inc.Feb 2016 · 18 co-filers$2.0M Tarsa Therapeutics, Inc.Mar 2012 · 12 co-filers$28.0M Tarsa Therapeutics, Inc.Mar 2012 · 12 co-filers$28.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Martin in the interactive graph →